Conclusion of a Cooperation Agreement between AGEPI and the National Medicines Agency


Increase of the role of intellectual property in the economic development of the country and the need to respect IP rights in various fields of activity becomes more and more evident every day. Becoming aware of the economic and social importance of enforcing security measures for products in the field of medicine and pharmaceutics and of preventing the spread of counterfeit products dangerous to human life and health, the State Agency on Intellectual Property (AGEPI) and the National Medicines Agency have concluded a Cooperation Agreement on May 25, 2010.

Signing of the Agreement was conditioned by the necessity to improve the law enforcement practice and to create conditions necessary to ensure an effective legal protection and defense of intellectual activity results and means of individualization of products in the field of medicine and pharmaceutics.

The cooperation will be achieved within the long-term partnership, Parties creating for this purpose a working group which will be responsible for the implementation of the provisions of said Agreement.